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Trimethylated H3K27 (H3K27me3) is associated with
transcriptional repression, and its abundance in
chromatin is frequently altered in cancer. However,
it has remained unclear how genomic regions modi-
fied by H3K27me3 are specified and formed. We pre-
viously showed that downregulation of transcription
by oncogenic Ras signaling precedes upregulation
of H3K27me3 level. Here, we show that lack of
transcription as a result of deletion of the transcrip-
tion start site of a gene is sufficient to increase
H3K27me3 content in the gene body. We further
found that histone deacetylation mediates Ras-
induced gene silencing and subsequent H3K27me3
accumulation. The H3K27me3 level increased gradu-
ally after Ras activation, requiring at least 35 days to
achieve saturation. Such maximal accumulation of
H3K27me3 was reversed by forced induction of tran-
scription with the dCas9-activator system. Thus, our
results indicate that changes in H3K27me3 level,
especially in the body of a subset of genes, are trig-
gered by changes in transcriptional activity itself.
INTRODUCTION
The elaborate control of histone modification is essential for
various eukaryotic cellular functions including transcriptional
regulation. Trimethylation at lysine-27 of histone H3 (H3K27)
is mediated by Polycomb repressive complex 2 (PRC2) and
associated with transcriptional repression (Di Croce and
Helin, 2013; Simon and Kingston, 2013). The distribution of tri-
methylated H3K27 (H3K27me3) throughout the genome has
been determined by genome-wide comprehensive analyses,
such as those based on deep chromatin immunoprecipitation
sequencing (ChIP-seq) (Dunham et al., 2012; Ernst et al.,
2011). Such analyses have revealed an inverse relation between
H3K27me3 level and transcriptional activity for various subsets
of genes, including those encoding Hox proteins, cell-cycle reg-
ulators, and transcription factors. Although these observations
have suggested that H3K27me3 plays a key role in transcrip-
tional repression, they have not revealed the hierarchical order696 Cell Reports 16, 696–706, July 19, 2016 ª 2016 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://among recruitment of PRC2, deposition of H3K27me3, and
transcriptional repression. Thus, it has remained unclear how
genomic regions covered with H3K27me3 are specified and
formed.
Studies in Drosophila have identified Polycomb response
elements (PREs) to which PRC2 is recruited by specific DNA-
binding proteins, such as PHO (Schwartz and Pirrotta, 2007).
PRC2 is required for maintenance of the repressed state of
geneswhose expression has already been attenuated by repres-
sive transcriptional factors, including segmentation gene prod-
ucts. On the other hand, establishment of gene silencing by
PRC2 at PREs is prevented by the Trithorax complex, which me-
diates the trimethylation of H3K4 and transcriptional activation
(Poux et al., 2002). These observations suggest that transcrip-
tional activity itself plays a role in the regulation of PRC2 at
PREs. However, it remains controversial whether transcription
through PREs impedes the access of PRC2 (Erokhin et al.,
2015; Schmitt et al., 2005). Furthermore, differences in PRC2
function and regulation have been detected among species,
and definitive PREs corresponding to those in Drosophila have
not been identified in mammalian cells to date (Bauer et al.,
2016).
Recent studies with mammalian cells have shown that CpG
islands have the potential to be targeted by PRC2 (Mendenhall
et al., 2010) and that PRC2 is recruited to specific regions of
DNA by several mechanisms mediated by noncoding RNA
(da Rocha et al., 2014; Sarma et al., 2014), transcription fac-
tors (Dietrich et al., 2012), or PRC1-dependent ubiquitylation
of histone H2A (Blackledge et al., 2014; Kalb et al., 2014).
On the other hand, the possibility of regulation of PRC2
recruitment by transcription has been suggested by several
observations, including the finding that prevention of RNA
polymerase II function with chemical inhibitors increased
H3K27me3 abundance at CpG islands in embryonic stem
cells (ESCs) (Riising et al., 2014). Moreover, H3K27me3 depo-
sition in the gene body was found to be induced when tran-
scription was prematurely interrupted by insertion of polyade-
nylation site in ESCs (Kaneko et al., 2014). These various
observations suggest that recruitment or activation of PRC2
follows transcriptional repression. At least two mechanisms
of H3K27me3 deposition in mammals have therefore been
proposed: active recruitment of PRC2 by specific binding
partners and passive recruitment of PRC2 after transcriptional
repression (Blackledge et al., 2015).creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Lack of Transcription Is Sufficient to Induce Accumulation of H3K27me3 in the Gene Body of Ephx1
(A) H3K27me3 level at the Ephx1 locus as revealed by our previous ChIP-seq analysis of control NIH 3T3 cells (NIH Vector) and cells at 12 days after the onset of
H-Ras (G12V) (RasG12V) expression conferred by retroviral infection (NIH Ras day12). The positions of ChIP-qPCR primers are indicated by the lowercase
letters (a–j). The black bar indicates the region targeted by the CRISPR/Cas9 genome editing system. Reads per million (RPMs) are used for the y axis in each
track.
(legend continued on next page)
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Lack or mutation of PRC2 components results in develop-
mental defects during embryogenesis or in tumorigenesis, indi-
cating the physiological relevance of H3K27me3 (Kim and
Roberts, 2016; Surface et al., 2010). Furthermore, various envi-
ronmental and developmental signals are known to regulate
H3K27me3 levels dynamically. The small GTPase Ras transmits
signals triggered by growth factor stimulation to downstream-
signaling pathways, including those mediated by mitogen-acti-
vated protein kinases (MAPKs) (Karnoub and Weinberg, 2008).
Activating mutations of Ras are one of the most frequent types
of oncogenic mutation in human cancer. We have shown previ-
ously that oncogenic Ras signaling represses transcription of
a subset of genes in association with a gradual increase in
H3K27me3 level in cultured cells (Hosogane et al., 2013).
Although our results indicated that transcriptional repression
precedes upregulation of H3K27me3 in this experimental model
of abnormal epigenetic modification in cancer, it has remained
unclear whether physiological changes in H3K27me3 level
induced by Ras signaling are a cause or consequence of
changes in transcription.
We have now further examined the causal nature of the rela-
tion between H3K27 trimethylation and transcriptional silencing
in response to activation of Ras signaling. With the use of the
CRISPR/Cas9 system for genome editing tomanipulate the state
of transcription directly, we obtained evidence showing that
transcription itself regulates H3K27me3 status and that the
Ras-induced changes in H3K27me3 level are not completed until
at least 30 days after those in transcription.
RESULTS
Lack of Transcription, but Not Ras Signaling, Is
Sufficient to Induce H3K27 Trimethylation
Ephx1 is silenced by activation of Ras-MAPK signaling in NIH
3T3 mouse fibroblasts (Figure S1), and this silencing is accom-
panied by marked enrichment of H3K27me3 in the gene body
(Figure 1A). We first examined whether Ras signaling or lack of
transcription itself induces the change in H3K27me3 level of
Ephx1. To silence gene expression without activating Ras
signaling, we deleted a genomic region containing the transcrip-
tion start site (TSS) of Ephx1with the use of CRISPR/Cas9-medi-
ated genome engineering in NIH 3T3 cells (Ran et al., 2013;
Zheng et al., 2014). We therefore designed two single-guide
RNAs (sgRNAs) that target a 1.5-kb genomic region around the
annotated TSS of Ephx1 (Figure 1B). This region includes most
of the H3K4me3 and RNA polymerase II peaks, which are indic-
ative of the promoter region, as revealed by a public ChIP-seq
database for mouse embryonic fibroblasts (MEFs). We trans-(B) ChIP-seq data for H3K4me3 and RNA polymerase II (Pol II) derived from Encyc
Arrowheads represent the positions of sgRNAs, numbered arrows indicate prime
region.
(C) Genotyping PCR analysis of parental NIH 3T3 cells as well as of cells heteroz
generated with the CRISPR/Cas9 system is shown. WT, wild-type.
(D) RT-qPCR analysis of Ephx1 expression in three independent Ephx1 TSS kno
(E–G) ChIP-qPCR analysis of H3K27me3 (E), H3K36me3 (F), and H3K27ac (G) at th
for three independent clones.
See also Figure S1.
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pyogenes Cas9 (SpCas9) and the two sgRNAs, and then we
cloned the transfected cells for establishment of several Ephx1
TSS-deleted cell lines. Deletion of the TSS of Ephx1 was
confirmed by genomic PCR analysis (Figure 1C).
As expected, transcription of Ephx1 was abolished in the
Ephx1 TSS-deleted cells (Figure 1D). ChIP and qPCRanalysis re-
vealed that the amount of H3K27me3 in the gene body of Ephx1
was markedly increased in these cells (Figure 1E). In contrast,
H3K27me3 levels in genomic regions external to Ephx1 were
similar in the Ephx1 TSS-deleted cells and parental cells, indi-
cating that H3K27me3 was upregulated only in the gene body
of Ephx1. Furthermore, consistent with the loss of Ephx1
mRNA (Figure 1D), the abundance of H3K36me3, which is an in-
dicator of transcriptional elongation, was greatly diminished
throughout the gene body of Ephx1 in the TSS-deleted cells
(Figure 1F), showing that the progression of RNA polymerase II
was inhibited. In contrast, the amount of acetylated H3K27
(H3K27ac), which localizes to promoter and enhancer regions,
was not substantially affected by deletion of the TSS of Ephx1
(Figure 1G). We found that the amount of H3K27me3 was not
increased in regions with a high H3K27ac level (regions f, h,
and i) in the TSS-deleted cells (Figures 1E and 1G), consistent
with previous results showing that acetylation and methylation
of the same lysine residue compete with each other (Pasini
et al., 2010).
We next examined whether a decrease in H3K27me3 level
associated with transcriptional activation is reversed by
CRISPR/Cas9-mediated transcriptional shutoff. For this pur-
pose, we examined Sorcs2, whose transcription is driven by
Ras signaling and is accompanied by removal of H3K27me3
from the gene body (Figure 2A). To delete the TSS of Sorcs2,
we introduced a pair of sgRNAs into NIH 3T3 cells expressing
a constitutively active mutant of human H-Ras (RasG12V). We
established several cell clones in which the TSS of Sorcs2
was homologously deleted (Figure 2B) and in which upregula-
tion of Sorcs2 expression by RasG12V was abolished, whereas
expression of the Ras-regulated genes Ephx1 and Bpil2 was
largely unaltered (Figure 2C). Ras signaling reduced the amount
of H3K27me3 throughout the gene body of Sorcs2 in parental
cells, consistent with our previous observations (Hosogane
et al., 2013), but this Ras-induced epigenetic alteration was
abrogated by TSS deletion (Figure 2D). The Ras-induced in-
crease in H3K36me3 abundance also was prevented by TSS
deletion (Figure 2E), indicating that transcriptional elongation
along the gene body of Sorcs2 was inhibited. These observa-
tions for Sorcs2 and Ephx1 thus showed that H3K27me3 accu-
mulation in the gene body was elicited by lack of transcriptionlopedia of DNA Elements (ENCODE) tracks around the TSS of Ephx1 in MEFs.
rs for genotyping PCR analysis in (C), and the black bar denotes the targeted
ygous (hetero) or homozygous (knockout) for the TSS-deleted allele of Ephx1
ckout clones relative to that in parental (WT) cells is shown.
e Ephx1 locus in parental and Ephx1 TSS knockout cells. Data are means ± SE
Figure 2. CRISPR/Cas9-Mediated Tran-
scriptional Shutoff Is Sufficient to Induce
Accumulation of H3K27me3 in the Gene
Body of Sorcs2
(A) H3K27me3 level at the Sorcs2 locus as deter-
mined by our previousChIP-seq analysis of control
NIH 3T3 cells and cells infected with a retrovirus
encoding RasG12V for 12 days. The positions of
ChIP-qPCR primers are indicated by lowercase
letters (a–f), and the black bar represents the po-
sition of the region deleted with the CRISPR/Cas9
system. RPMs are used for the y axis in each track.
(B) Genotyping PCR analysis of parental (WT) NIH
3T3cells aswell asof cells homozygous (knockout)
for the TSS-deleted allele ofSorcs2 generatedwith
the CRISPR/Cas9 system is shown.
(C) RT-qPCR analysis of Ephx1, Bpil2, and Sorcs2
expression in NIH 3T3 cells expressing (or not)
RasG12V with or without Sorcs2 TSS knockout.
Data aremeans ±SE for three independent clones.
(D and E) ChIP-qPCR analysis of H3K27me3 (D)
and H3K36me3 (E) in the gene body of Sorcs2 in
parental NIH 3T3 cells and cells expressing
RasG12V with or without Sorcs2 TSS knockout.
Data aremeans ±SE for three independent clones.of both genes and that Ras signaling was not required for this
epigenetic change.
Ras-Dependent Histone Deacetylation Induces Gene
Silencing and Deposition of H3K27me3
Time course analysis revealed that the PRC2 component Suz12
was gradually recruited to the gene body as well as the region
around the TSS after eviction of RNA polymerase II from Ephx1
in response to activation of Ras signaling (Figure 3A). These
data indicated that transcriptional repression is followed by
PRC2 recruitment and that accumulation of H3K27me3 is not
responsible for transcriptional repression by Ras signaling. We
next searched for othermolecular links between such signal acti-
vation and gene silencing. Acetylation of histone tails has been
shown to enhance transcription, and we therefore explored the
possibility that histone acetylation is controlled by the Ras-
signaling pathway. To this end, we performed ChIP-qPCR anal-
ysis with antibodies to H3K27ac and to H3K27me3 at variousCtimes after the infection of NIH 3T3 cells
with a retrovirus encoding RasG12V. We
analyzed the genomic region around the
TSS of Ephx1 for H3K27ac and that at
the 30 end of Ephx1 for H3K27me3. We
found that the amount of H3K27ac was
decreased markedly 2 days after Ras
activation, at which time the amount of
H3K27me3 remained unchanged (Fig-
ure 3B). Other acetylated forms of his-
tone tails, including H3K9ac and H4ac,
showed dynamics similar to those of
H3K27ac in response to Ras signal acti-
vation (data not shown). These observa-
tions suggested the possibility that his-tone deacetylation mediates Ras-induced gene silencing, with
H3K27me3 accumulating after transcriptional repression.
To test this hypothesis, we treated NIH 3T3 cells expressing
RasG12V with trichostatin A (TSA), an inhibitor of histone deace-
tylase activity, for 5 or 6 days beginning 2 days after the activa-
tion of Ras signaling (Figure 3C). Immunoblot analysis revealed
that total H3K27ac and H3K27me3 levels in NIH 3T3 cells were
not affected by expression of RasG12V (Figure 3D). TSA treat-
ment increased the total amount of H3K27ac in a concentra-
tion-dependent manner without affecting that of H3K27me3,
expression of Ras, or phosphorylation (activation) of the MAPKs
Erk1 and Erk2 (Figure 3D). Ras-induced deacetylation of
H3K27ac in the region around the TSS of Ephx1 was inhibited
by TSA at even lower concentrations (Figure 3E). Moreover, tran-
scription of Ephx1 (Figure 3F) as well as recruitment of RNA po-
lymerase II to the region around the TSS (Figure 3G) was restored
by TSA treatment to levels similar to those for parental NIH 3T3
cells. Of note, the accumulation of H3K27me3 at Ephx1 inducedell Reports 16, 696–706, July 19, 2016 699
Figure 3. Histone Deacetylation Is Required
for Ras-Induced Gene Silencing and Depo-
sition of H3K27me3 at Ephx1
(A) ChIP-qPCR analysis of Pol II and Suz12 binding
to Ephx1 at the indicated times after infection of
NIH 3T3 cells with a retrovirus encoding RasG12V.
Positions of ChIP-qPCR primers for this figure are
indicated in relation to Ephx1 structure. Data are
means ± SE for three independent experiments.
(B) ChIP-qPCR analysis of H3K27ac and
H3K27me3 with primer sets TSS and c, respec-
tively, at the indicated times after infection of NIH
3T3 cells with a retrovirus encoding RasG12V.
Data are means ± SE for three independent ex-
periments.
(C) Timeline for the introduction of RasG12V and
exposure to TSA for NIH 3T3 cells studied in (D)–(H)
is shown.
(D) Immunoblot analysis of H3K27ac, H3K27me3,
total H3 (loading control), H-Ras, phosphorylated
(p) and total forms of Erk1/2, and Hsp90 (loading
control) in NIH 3T3 cells infected with the retrovirus
encoding RasG12V (or the corresponding empty
virus, Vec) and treated with the indicated con-
centrations of TSA is shown.
(E–H) ChIP-qPCR analysis of the effects of
RasG12V and TSA both on H3K27ac level (E)
and Pol II recruitment (G) in the region around the
TSS of Ephx1 and on H3K27me3 level in the
gene body (H), as well as RT-qPCR analysis of
Ephx1 expression (F). Data for ChIP-qPCR are
means ± SE for two independent experiments,
whereas those for RT-qPCR are means ± SE for
four independent experiments.
See also Figure S2.by Ras activation was blocked by TSA (Figure 3H), suggesting
that H3K27 acetylation and transcription suppress deposition
of H3K27me3. Analysis of Itgb5 yielded similar results. Ras-
induced transcriptional repression and H3K27me3 deposition
at Itgb5 were thus also greatly attenuated by treatment with
TSA (Figure S2). Together these observations indicated
that Ras activation induces deacetylation of histone tails, which
is in turn responsible for gene silencing and subsequent
H3K27me3 accumulation at Ephx1 and Itgb5.
Ras-Induced Accumulation of H3K27me3 Is Not
Completed Until at Least 30 Days after Transcriptional
Repression
Our results suggested that a change in transcriptional activity
gradually influences the amount of H3K27me3 in the gene
body. To determine the time required for completion of the
change in H3K27me3 level induced by Ras activation, we
analyzed the amount of H3K27me3 at various times up to
45 days by ChIP-qPCR analysis. Transcription of Ephx1 was
suppressed after 5 days and remained silenced for up to
45 days (Figure 4A). By contrast, the amount of H3K27me3 along
the gene body of Ephx1 increased gradually and reached a700 Cell Reports 16, 696–706, July 19, 2016maximum after 35 days (Figure 4B). We also observed similar
time courses of transcription and H3K27me3 accumulation for
Itgb5 (Figures S3A and S3B), suggesting that the change in
H3K27me3 level for both genes takes at least 35 days to
complete.
We performed ChIP-seq analysis for H3K27me3 as well as
RNA sequencing (RNA-seq) analysis with the cells in which
Ras signaling had been activated for 35 days. The ChIP-seq
and RNA-seq results for the genomic locus containing Ephx1
are shown together with our previous short-term time course
data for H3K27me3 ChIP-seq obtained 0, 2, 4, 7, and 12 days
after Ras activation (Figure 4C). In general, H3K27me3 did not
manifest focal enrichment, but rather accumulated over several
tens of kilobases of the genomic region. Visual inspection re-
vealed that the amount of H3K27me3 in the gene body of
Ephx1wasmuch higher at 35 days than at the other time points,
confirming that H3K27me3 is deposited progressively over
time. To quantitate the H3K27me3 level, we used a peak caller
that is optimized for detection of broad peaks. As exemplified
by the Ephx1 locus in Figure 4C, broad peaks of H3K27me3
were identified at 0 and 35 days after Ras activation. This anal-
ysis revealed that 18.7% of the entire genomewas covered with
Figure 4. Accumulation of H3K27me3 at
Ephx1 Continues for at Least 35 Days after
Ras Activation
(A) RT-qPCR analysis of Ephx1 mRNA at the indi-
cated times after introduction of RasG12V into NIH
3T3 cells. Data are means ± SE for three inde-
pendent experiments.
(B) ChIP-qPCR analysis of H3K27me3 at the Ephx1
locus at the indicated times after introduction
of RasG12V into NIH 3T3 cells. The positions of
primers for ChIP-qPCR are depicted at the top of
the panel. Data are means ± SE for five indepen-
dent experiments.
(C) Time course of changes in H3K27me3 content
at the genomic region containing the Ephx1 locus,
as determined by ChIP-seq analysis of NIH 3T3
cells infected with a retrovirus for RasG12V (Ras35)
or the corresponding empty virus (Vec) for 35 days.
These new data are shown together with the re-
sults of our previous ChIP-seq analysis for cells at
0, 2, 4, 7, or 12 days after Ras activation. Black
bars represent identified broad peaks. RPMs are
used for the y axis in each track. The expression
level of Ephx1 (fragments per kilobase of exon
model per million mapped reads [FPKMs]) as
determined by RNA-seq analysis is shown at the
right of each track.
(D) Percentage coverage of the entire genome with
H3K27me3. Peaks in 2.9% and 5.9% of the
genome are newly formed or lost, respectively, in
response to Ras activation. Peaks identified in both
control and RasG12V-expressing cells cover
18.7% of the genome, whereas no peak was
identified under either condition over 72.5% of the
genome.
(E) Normalized read counts for H3K27me3 ChIP-
seq analysis of genomic regions (>30 kb) at the indicated times after the introduction of RasG12V into NIH 3T3 cells. The total number of H3K27me3 ChIP-seq
reads was adjusted to ten million, and read counts within each region were normalized by region size (reads/base pair). Averaged values of normalized read
counts for regions classified as in (D) are shown with SD values. The normalized value for the single region containing Ephx1 also is shown.
See also Figure S3.such broad peaks, in both control and RasG12V-expressing
cells, and that 72.5% of the entire genome was devoid of
such broad peaks in both types of cells (Figure 4D). Further-
more, 2.9% or 5.9% of the entire genome was not covered
with H3K27me3 at day 0 but was covered at 35 days after
Ras activation or vice versa.
We then calculated the normalized H3K27me3 signal within
each defined H3K27me3 domain for each time point. The
mean signals for both the common regions covered with
H3K27me3 broad peaks and the common uncovered regions re-
mained constant from 0 to 35 days after Ras activation (Fig-
ure 4E). In contrast, the signals for the regions covered in only
control or RasG12V-expressing cells continued to change from
0 to 35 days (Figure 4E). Of note, the normalized H3K27me3
signal in the region containing Ephx1 also showed a gradual in-
crease (Figure 4E), with the level at 35 days being much higher
than that at 12 days and similar to that for common covered re-
gions.We obtained similar, although less pronounced, results for
the genomic region containing Itgb5 (Figure S3C). On the basis of
these data, we concluded that changes in H3K27me3 content,
especially around the Ephx1 locus, were not completed until at
least 35 days after Ras activation.Transcriptional Activation with the dCas9-Activator
System Erases H3K27me3 Deposited in the Gene Body
of Ephx1 in Response to Long-Term Ras Activation
To determine whether transcriptional activation is sufficient for
removal of H3K27me3 broad peaks, we activated Ephx1 tran-
scription with the use of the dCas9-activator system based on a
catalytically inactive mutant of Cas9 (dCas9) (Konermann et al.,
2015). Variousproteins fused todCas9canbe recruited tospecific
genomic regions in the presence of sgRNAs. We first introduced
RasG12V into NIH 3T3 cells and cultured the cells for at least
30days in order to allow completion ofH3K27me3peak formation
aroundEphx1.We thensequentially introduced threecomponents
into the cells to activate Ephx1 transcription (Figure 5A): a fusion
protein consisting of dCas9 and the transcriptional activator
Vp64 (dCas9-Vp64), a fusionprotein containing thebacteriophage
coat protein MS2 and the transactivation domains of p65 and
HSF1 (MS2-p65HSF1), and a fusion RNA that includes the sgRNA
and an RNA sequence with an MS2-binding site (sgRNA-
MS2RNA) and mediates the recruitment of dCas9-Vp64 and
MS2-p65HSF1 to the promoter region of Ephx1 (Figure 5B).
Immunoblot analysis showed that dCas9-Vp64 was efficiently
expressed without affecting the amount of Ras protein or theCell Reports 16, 696–706, July 19, 2016 701
Figure 5. Transcriptional Activation Is Suffi-
cient to Reverse H3K27me3 Accumulation
at Ephx1 Induced by Long-Term Activation
of Ras Signaling
(A) Schematic representation shows the complex
formed by dCas9-Vp64, MS2-p65HSF1, and
sgRNA-MS2RNA in the upstream region of Ephx1.
(B) Timeline for experimental manipulation of
Ephx1 transcription in NIH 3T3 cells is shown. Ctrl,
control.
(C) Immunoblot analysis of dCas9, H-Ras, phos-
phorylated (p) and total forms of Erk1/2, and Hsp90
(loading control) in NIH 3T3 cells expressing the
indicated components is shown.
(D) RT-qPCR analysis of Ephx1 expression in the
manipulated cells. Data are means ± SE from two
independent experiments.
(E) ChIP-qPCR analysis of H3K27me3 along the
gene body of Ephx1 in the manipulated cells. The
positions of PCR amplicons are as depicted in
Figure 1A. Data are means ± SE from three inde-
pendent experiments.extent of downstream-signaling activity, as indicated by the
phosphorylation level of Erk1/2 (Figure 5C). Transcription of
Ephx1 was suppressed by RasG12V, and this suppression was
reversed by targeting of the Ephx1 promoter by the specific
sgRNA, but it was not affected by a control sgRNA (Figure 5D).
Importantly, the increase in H3K27me3 level induced by Ras
signaling also was reversed by the specific sgRNA, but not by
the control sgRNA (Figure 5E). Such an effect on H3K27me3
level was not observed in genomic regions external to the gene
body of Ephx1 (Figure 5E), possibly suggesting the importance
of RNA polymerase II for erasure of H3K27me3. Collectively,
these results showed that transcription itself erased broad peaks
of H3K27me3 that had accumulated in response to prolonged
activation of Ras signaling.
Effects of Forced Transcriptional Control on the Focal
H3K27me3 Peak at the CpG-Rich Promoter of Smad6
Given that CpG islands are thought to be potential targets of
PRC2 in mammalian cells (Mendenhall et al., 2010), we exam-
ined whether our results for gene bodies also might extend to
H3K27me3 at CpG-rich promoters. We and others have shown
that Ras signaling generates a focal H3K27me3 peak at the
CpG-rich promoter of Smad6 (Hosogane et al., 2013; Kaneda
et al., 2011). In contrast to the other genes studied here, Ras702 Cell Reports 16, 696–706, July 19, 2016induced the accumulation of H3K27me3
predominantly in the promoter region
and, to a lesser extent, in the gene body
of Smad6 (Figure 6A; Figure S4A).
We established several NIH 3T3 cell
clones in which the TSS of Smad6
was homologously deleted (Figure 6B).
The expression level of Smad6 in
these clones was even lower than
that apparent after Ras-induced gene
silencing in parental cells (Figure 6C).
Although Ras signaling increased thelevel of H3K27me3 around the CpG island in parental cells, tran-
scriptional inhibition by TSS deletion did not trigger the focal
accumulation of H3K27me3 in this region (Figure 6E). Of note,
we observed an increase in H3K27me3 abundance in the
gene body in response to either Ras activation or TSS deletion
at sites at which the amount of H3K36me3 decreased (Figures
6D and 6E). These observations thus suggested that
H3K27me3 accumulation around the CpG island of Smad6
was not induced by abrogation of transcription alone, with
Ras signaling or a DNA element within the deleted region also
being required.
We also activated Smad6 transcription with the use of the
dCas9-activator system. Suppression of Smad6 transcription
by RasG12V was reversed by targeting of the gene promoter
with two different specific sgRNAs (Figure S4B). Consistent
with this result, the amount of H3K4me3 around the CpG island
was reduced in RasG12V-expressing cells, but it was recovered
in cells also expressing specific sgRNAs (Figure S4C). Impor-
tantly, the increase in H3K27me3 level induced by Ras signaling
also was reversed by the specific sgRNAs, both around the CpG
island as well as in the gene body of Smad6 (Figure S4D). Collec-
tively, these results suggested that transcriptional activation is
sufficient for removal of a focal peak of H3K27me3 around a
CpG island.
Figure 6. TSS Deletion Does Not Induce
Accumulation of H3K27me3 at the CpG-
Rich Promoter of Smad6
(A) Our ChIP-seq analysis of H3K27me3 level at the
Smad6 locus in control NIH 3T3 cells (NIH Vector)
and cells at 35 days after the onset of RasG12V
expression (NIH Ras35) are shown together with
ChIP-seq data for H3K4me3 in MEFs, GC per-
centage content, and CpG islands derived from
public databases. RPMs are used on the y axis for
H3K27me3 ChIP-seq. The positions of ChIP-qPCR
primers are indicated by the lowercase letters
(a–c), and the black bar denotes the targeted re-
gion for TSS deletion.
(B) Genotyping PCR analysis of parental (WT) NIH
3T3 cells as well as of cells homozygous for the
TSS-deleted allele of Smad6 generated with the
CRISPR/Cas9 system is shown.
(C) RT-qPCR analysis of Smad6 expression in
Smad6 TSS knockout cells and RasG12V-ex-
pressing cells relative to that in parental (WT) NIH
3T3 cells. Data are means ± SE from three inde-
pendent experiments (RasG12V-expressing cells)
or three independent clones (TSS knockout).
(D and E) ChIP-qPCR analysis of H3K36me3 (D)
and H3K27me3 (E) at the Smad6 locus in parental,
RasG12V-expressing, and Smad6 TSS knockout
cells. Data are means ± SE from three independent
experiments (RasG12V-expressing cells) or three
independent clones (TSS knockout).
See also Figure S4.DISCUSSION
Although Ras signaling affects transcription and H3K27me3
level, the relation between and sequence of these events
have remained unclear. We have now shown that Ras-induced
changes in H3K27me3 level in the gene body are dependent
on transcriptional changes. We further found that histone de-
acetylation is required for Ras-induced changes in both
transcription and H3K27me3 level. In addition, we found that
the accumulation of H3K27me3 in the gene body of Ephx1
induced by constitutive Ras signaling required at least
35 days to reach a plateau, and we learned that even this
maximal level of H3K27me3 deposition was erased by
forced activation of transcription. The focal accumulation of
H3K27me3 around the CpG island of Smad6 was not induced
by TSS deletion, however, although such focal deposition of
H3K27me3 was erased by forced activation of transcription.
Collectively, our results thus show that transcription itself reg-
ulates H3K27me3 level in the body of at least a subset of
genes in cells with activated Ras signaling.CMolecular Mechanism of
H3K27me3 Accumulation Induced
by Transcriptional Inhibition
Chemical inhibition of RNA polymerase
II with 5,6-dichloro-1-b-D-ribofuranosyl-
benzimidazole (DRB) or triptolide recently
was shown to increase H3K27me3 abun-
dance at CpG islands in mouse ESCs(Riising et al., 2014). This finding together with our present results
indicates that certain genomic sequences have the potential to
be targeted by PRC2 in the basal, untranscribed state, as has
been proposed in the chromatin sampling model (Klose et al.,
2013). This model suggests that RNA polymerase II itself might
erase or prevent the deposition of H3K27me3 as it proceeds
along the transcribed region.
At least three mechanisms have been proposed for the pre-
vention of methyl mark deposition by RNA polymerase II: (1)
given that the enzymatic activity of the PRC2 component
Ezh2 is inhibited by RNA, active transcription by RNA polymer-
ase II may maintain Ezh2 in an inactive state (Cifuentes-Rojas
et al., 2014; Kaneko et al., 2013); (2) the enzymatic activity of
Ezh2 is enhanced by compact chromatin where transcription
is repressed (Yuan et al., 2012), and this effect would be
reversed by the recruitment of RNA polymerase II; and (3)
RNA polymerase II attracts H3K36 methyltransferase to the
gene body via physical interaction, with H3K36me3 in turn hav-
ing an inhibitory effect on PRC2 activity (Musselman et al., 2012;
Schmitges et al., 2011; Yuan et al., 2011). Consistent with thisell Reports 16, 696–706, July 19, 2016 703
third possibility, we observed a mutually exclusive relation
between H3K27me3 and H3K36me3 in cells with activated
Ras signaling. Manipulation of transcription with the use of
the CRISPR/Cas9 system provides direct insight into the causal
nature of the relation between changes in transcription and
epigenetic modification, and it represents a complementary
approach for genome-wide comprehensive analysis. Further
analytic substantiation is required to understand the molecular
mechanisms of the chromatin sampling model as well as other
possibilities.
Effects of TSS Deletion on Focal and Broad H3K27me3
Accumulation
We have shown here that the lack of transcription as a result of
TSS deletion is sufficient to induce the accumulation of
H3K27me3 in the gene body of Ephx1 and Sorcs2. On the other
hand, deletion of the TSS ofSmad6 did not induce focal accumu-
lation of H3K27me3 in the gene promoter, but it did increase the
amount of H3K27me3 in the gene body at sites at which the
amount of H3K36me3 was decreased. It is thus possible that
deletion of the 3.3-kb genomic region containing the TSS of
Smad6 also resulted in the loss of a DNA element responsible
for the recruitment of PRC2. Given that CpG islands are thought
to be potentially targeted by PRC2 in mammals, abrogation of
transcription by CpG island deletion might not be sufficient to
induce focal H3K27me3 accumulation. Our data are consistent
with the previous observation that the inhibition of RNA polymer-
ase II results in preferential accumulation of H3K27me3 at CpG
islands (Riising et al., 2014).
Ras-Induced Histone Deacetylation Triggers
Accumulation of H3K27me3
Studies of PREs in Drosophila have shown that PRC2 is not
required for the triggering of transcriptional repression, but it is
needed formaintenance of the repressed state of genes at which
repression has already been established (Schwartz and Pirrotta,
2007). We also have found that initial repression was preceded
by histone deacetylation, but it did not require PRC2 in the
context of gene silencing dependent on Ras-MAPK signaling
(Hosogane et al., 2013). Similarly, in ESCs, NuRD-mediated de-
acetylation of H3K27ac was found to promote PRC2 recruitment
and subsequent H3K27me3 formation (Reynolds et al., 2012).
Histone acetylation provides a docking site for TFIID (Filippako-
poulos et al., 2012), and H3K27ac is known to compete with
H3K27me3 (Pasini et al., 2010). Activation of Ras-MAPK
signaling thus induces histone deacetylation, which might result
in disruption of the TFIID complex at the promoter and provide
substrates for PRC2.
MAPK has been found to be recruited to the TSS in order to
phosphorylate serine-5 of RNA polymerase II and to regulate
PRC2 in mouse ESCs (Tee et al., 2014). RNA polymerase II
also is phosphorylated in response to Ras-MAPK signaling in so-
matic cells (Bonnet et al., 1999; Dubois et al., 1994), and we
observed an increase in the abundance of the phosphorylated
form of RNA polymerase II in RasG12V-expressing NIH 3T3 cells
(data not shown). These data suggest that MAPK signaling might
have effects on H3K27me3 levels other than that dependent on
deacetylation.704 Cell Reports 16, 696–706, July 19, 2016Formation of Broad Peaks of H3K27me3 in Response to
Transcriptional Repression
ChIP-seq analysis has revealed that H3K27me3 covers contin-
uous genomic regions ranging from several tens to hundreds
of kilobases in differentiated cells. These broad H3K27me3 do-
mains show a cell type-specific distribution and have been
designated broad local enrichments (BLOCs) (Brinkman et al.,
2012; Pauler et al., 2009; Zhu et al., 2013), but the mechanism
underlying their formation has remained unknown. We examined
H3K27me3 accumulation in response to Ras activation to shed
light on this mechanism. We found that constitutive Ras activa-
tion results in a high level of H3K27me3 accumulation from the
TSS to the transcription termination site of Ephx1. This deposi-
tion of H3K27me3 in the gene body of Ephx1, together with
the flanking genomic regions that are already fully decorated
with this modification, gives rise to the formation of a large
H3K27me3 domain similar to a BLOC. In contrast to acute
changes in H3K27ac level, this change in H3K27me3 level pro-
gressed slowly and required at least 35 days for its completion.
These observations suggest that H3K27me3 BLOCs in differen-
tiated cells are established by the combination of prolonged
gene silencing (in the case of the gene body) and the absence
of transcription in intergenic regions.
The H3K27me3 BLOC-like domain encompassing the gene
body of Ephx1 was readily removed, however, by forced tran-
scription with the dCas9-activator system. Moreover, we previ-
ously showed that Ras-induced H3K27me3 accumulation is
insufficient to maintain the repressed state of a gene after inac-
tivation of the Ras signal (Hosogane et al., 2013). These observa-
tions are consistent with the mutual antagonistic relation be-
tween Polycomb group proteins and transcription (Steffen and
Ringrose, 2014). It remains unclear whether this antagonistic na-
ture of H3K27me3 is related to epigenetic control of transcription
in differentiated NIH 3T3 cells. Further studies are required to
determine whether H3K27me3 plays a role in epigenetic memory
andmaintenance of the repressed state of genes in NIH 3T3 cells
with activated Ras signaling, as seen in cells during differentia-
tion in both Drosophila and mammals.
EXPERIMENTAL PROCEDURES
Experimental details in addition to those presented below can be found in the
Supplemental Experimental Procedures.
Cells and sgRNA Design
NIH 3T3 cells were obtained from American Type Culture Collection (CRL-
1658). The sgRNAs for deletion of the TSS of Ephx1, Sorcs2, or Smad6 were
designed with the use of the online CRISPR Design Tool (http://crispr.mit.
edu) and were subcloned into pSpCas9(BB)-2A-Puro. The sgRNAs targeting
the promoter of Ephx1 or Smad6 were designed with the use of the
Cas9 Activator Tool (http://sam.genome-engineering.org/database) and
were subcloned into lenti sgRNA(MS2)_zeo backbone. Sequences of sgRNAs
are provided in the Supplemental Experimental Procedures.
Establishment of Ephx1 TSS or Smad6 TSS Knockout Cells and of
Sorcs2 TSS Knockout Cells Expressing RasG12V
Deletion of a genomic region containing the TSS was induced by introduction
of a pair of pSpCas9(BB)-2A-Puro-based plasmids into parental NIH 3T3 cells
(for Ephx1 TSS or Smad6 TSS deletion) or into NIH 3T3 cells expressing
RasG12V (for Sorcs2 TSS deletion) by transient electroporation with the use
of the Neon Transfection System (Life Technologies). The cells were then
cloned by the limiting dilution method in 96-well plates. The resulting single
cell-derived clones were screened for homozygous deletion by genomic
PCR analysis with primers listed in the Supplemental Experimental
Procedures.
Establishment of a Stable Cell Line Expressing dCas9-Vp64 and
MS2-p65HSF1
The lenti dCAS-VP64_Blast and MS2-P65-HSF1_GFP vectors were intro-
duced into NIH 3T3 cells expressing RasG12V by lentivirus infection. The in-
fected cells were then subjected to selection in medium containing blasticidin
(5 mg/ml), after which the GFP-positive population was sorted by flow cytom-
etry with a BD FACS Aria2 instrument (BD Biosciences). The isolated cells, in
which dCAS-VP64_Blast and MS2-P65-HSF1_GFP were stably integrated,
were expanded and stored for subsequent lentivirus infection to introduce a
lenti sgRNA(MS2)_zeo construct targeting the Ephx1 or Smad6 promoter.
Immunoblot Analysis
Immunoblot analysis was performed with antibodies to H-Ras (sc-520, Santa
Cruz Biotechnology), Erk1/2 (9102, Cell Signaling Technology), phosphory-
lated Erk1/2 (9101, Cell Signaling Technology), Cas9 (MAC133, Millipore),
Hsp90 (610418, BD Biosciences), H3K27me3 (07-449, Millipore), H3K27ac
(8173, Cell Signaling Technology), and histone H3 (ab1791, Abcam).
RT-qPCR Analysis
RT-qPCR analysis was performed with primers listed in the Supplemental
Experimental Procedures. Data were analyzed according to the 2–DDCt method
and were normalized by the amount of Hprt or Arbp mRNA.
ChIP-qPCR Analysis
ChIP was performed with antibodies to H3K27me3 (07-449, Millipore),
H3K36me3 (MABI0333, MBL), H3K27ac (8173, Cell Signaling Technology),
H3K4me3 (04-745, Millipore), Suz12 (3737, Cell Signaling Technology), or
RNA polymerase II (8WG16; ab817, Abcam) together with Protein A
Dynabeads or Protein G Dynabeads (Life Technologies). Precipitated DNA
was subjected to qPCR analysis, and data were analyzed according to the
2–(Ct of IP sample – Ct of input sample) method and are presented as a percentage
of input or fold change. Primer sequences are listed in the Supplemental
Experimental Procedures.
ChIP-seq and RNA-seq
For comprehensive analysis of changes in gene expression and H3K27me3
content induced by long-term activation of Ras signaling, we performed
RNA-seq and ChIP-seq analyses at 35 days after infection of NIH 3T3 cells
with a retrovirus encoding RasG12V (Ras35) or with the corresponding empty
virus (Vec). Figures were constructed from screen shots of the University of
California, Santa Cruz (UCSC) Genome Browser with our previous time course
data for H3K27me3 ChIP-seq [DNA Data Bank of Japan Sequence Read
Archive, DRA: DRA001075].
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